Skip to main content
. Author manuscript; available in PMC: 2008 Sep 24.
Published in final edited form as: Anal Chem. 2007 Jun 28;79(15):5878–5887. doi: 10.1021/ac0701738

Figure 6.

Figure 6

Assessment of in vivo proteolysis of cysC in patients with multiple sclerosis. SAMDI-TOF spectra show the capture of cysC from normal human plasma, normal human serum, two control CSF samples presenting other neurological diseases (OND), and seven CSF samples from patients with multiple sclerosis (MS).